Elimination profile of low‐dose chlortalidone and its detection in hair for doping analysis—Implication for unintentional non‐therapeutic exposure
Authors:
Open Access
- 19 February 2024
- journal article
- research article
- Published by Wiley in Drug Testing and Analysis
- Vol. 16 (11) , 1378-1383
Abstract
Chlortalidone (CLT) is a thiazide‐type diuretic with high affinity for the erythrocyte carbonic anhydrase. Therapeutically, it is mostly used to treat edema and hypertension due to liver cirrhosis, heart insufficiency, or renal dysfunction. Although diuretics and masking agents are prohibited by the World Anti‐Doping Agency (WADA) at all times in sports, substances belonging to this category are constantly detected in athlete samples, according to WADA's annual testing figures. Within this group of structurally diverse compounds, a threshold of 20 ng/mL has been introduced for six substances solely due to their presence as contaminants in other permitted drugs because of pharmaceutical production processes. In a recent presumptive doping case with a low urinary CLT concentration, the question of unintentional doping, for example, by contaminated non‐steroidal anti‐inflammatory drug intake, arose. To examine this potential scenario, a co‐elimination of low‐dose CLT and hydrochlorothiazide (HCTA; 20 × 50 μg, 0.2 mg/day each) was conducted on five consecutive days in two volunteers. Urine samples were subjected to liquid chromatography‐tandem mass spectrometry (LC–MS/MS). Moreover, we examined the incorporation of CLT in scalp hair. HCTA is rapidly excreted renally in comparatively high concentrations. In contrast, the elimination of CLT is considerably slower (terminal elimination half‐life extended by a factor of 12) and, consequently, much less concentrated in corresponding urine samples (45 and 53 ng/mL, respectively). Conversely, a higher hair incorporation of chlorthalidone was observed with simultaneous dosing of both. The results suggest that an unintentional intake of sub‐therapeutic CLT doses due to contamination might result in an adverse analytical finding.Keywords
This publication has 18 references indexed in Scilit:
- The presence of doping agents in dietary supplements: A glimpse into the Brazilian situationDrug Testing and Analysis, 2023
- Screening and elucidation of fragmentations of 23 diuretics in dietary supplements using UHPLC-Q-OrbitrapScience & Justice, 2021
- Multiple incidence of the prescription diuretic hydrochlorothiazide in compounded nutritional supplementsDrug Testing and Analysis, 2018
- First identification of a diuretic, hydrochlorothiazide, in hair: Application to a doping case and interpretation of the resultsDrug Testing and Analysis, 2018
- Detection of the diuretic hydrochlorothiazide in a doping control urine sample as the result of a non-steroidal anti-inflammatory drug (NSAID) tablet contaminationForensic Science International, 2016
- Segmental hair analysis for differentiation of tilidine intake from external contamination using LC‐ESI‐MS/MS and MALDI‐MS/MS imagingDrug Testing and Analysis, 2014
- Metabolism of Diuretics1995
- Dose‐dependent urinary excretion of chlorthalidoneClinical Pharmacology & Therapeutics, 1979
- Interindividual differences in chlorthalidone concentration in plasma and red cells of man after single and multiple dosesEuropean Journal of Clinical Pharmacology, 1976
- Binding‐site interaction of chlorthalidone and acetazolamide, two drugs transported by red blood cellsClinical Pharmacology & Therapeutics, 1975